Literature DB >> 15149584

Treatment Options for Primary Constipation.

Vijayamalini Pampati1, Ronald Fogel.   

Abstract

Patients suffering from primary constipation often show symptom improvement with increased intake of fiber. Bulk laxatives are a core component of treatment if dietary fiber is unsuccessful in alleviating symptoms. Although there are a number of commercial laxative preparations available, only polyethylene glycol (PEG), an osmotic laxative, should be used on a daily basis. For the elderly, saline laxatives may be used on a regular basis, provided there are no cardiac or renal comorbid contraindications. Tegaserod, a 5-HT(4) partial receptor agonist, is approved for the treatment of constipation in female patients. The appropriate role of biofeedback remains to be determined. Surgery should be reserved for patients with slow transit constipation refractory to medical therapy. Patients being considered for surgery should be evaluated at institutions with substantial expertise in the investigation and management of this population.

Entities:  

Year:  2004        PMID: 15149584     DOI: 10.1007/s11938-004-0043-z

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  40 in total

Review 1.  Is chronic use of stimulant laxatives harmful to the colon?

Authors:  Arnold Wald
Journal:  J Clin Gastroenterol       Date:  2003 May-Jun       Impact factor: 3.062

2.  Raynaud's phenomenon induced by drugs acting on neurotransmission: two cases under reboxetine and one under tegaserod.

Authors:  Raffaela Bertoli; François Girardin; Stefan Russmann; Bernhard H Lauterburg
Journal:  Eur J Clin Pharmacol       Date:  2003-01-29       Impact factor: 2.953

Review 3.  Chronic constipation.

Authors:  Anthony Lembo; Michael Camilleri
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

Review 4.  Surgery for constipation: a review.

Authors:  J Pfeifer; F Agachan; S D Wexner
Journal:  Dis Colon Rectum       Date:  1996-04       Impact factor: 4.585

5.  Botulinum toxin type-A in therapy of patients with anismus.

Authors:  Y Ron; Y Avni; A Lukovetski; J Wardi; D Geva; S Birkenfeld; Z Halpern
Journal:  Dis Colon Rectum       Date:  2001-12       Impact factor: 4.585

6.  Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health status.

Authors:  W E Whitehead; D Drinkwater; L J Cheskin; B R Heller; M M Schuster
Journal:  J Am Geriatr Soc       Date:  1989-05       Impact factor: 5.562

7.  Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation.

Authors:  C E J Sloots; A C Poen; R Kerstens; M Stevens; M De Pauw; J C Van Oene; S G M Meuwissen; R J F Felt-Bersma
Journal:  Aliment Pharmacol Ther       Date:  2002-04       Impact factor: 8.171

8.  Position of the American Dietetic Association: health implications of dietary fiber.

Authors:  Judith A Marlett; Michael I McBurney; Joanne L Slavin
Journal:  J Am Diet Assoc       Date:  2002-07

9.  Prucalopride, a systemic enterokinetic, for the treatment of constipation.

Authors:  A V Emmanuel; A J Roy; T J Nicholls; M A Kamm
Journal:  Aliment Pharmacol Ther       Date:  2002-07       Impact factor: 8.171

10.  An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome.

Authors:  J Kellow; O Y Lee; F Y Chang; S Thongsawat; M Z Mazlam; H Yuen; K A Gwee; Y T Bak; J Jones; A Wagner
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

View more
  5 in total

1.  Pelvic outlet obstruction.

Authors:  Orit Kaidar-Person; Seth A Rosen; Steven D Wexner
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

Review 2.  Treating chronic constipation : How should we interpret the recommendations?

Authors:  David A Johnson
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

3.  Higher molecular weight polyethylene glycol increases cell proliferation while improving barrier function in an in vitro colon cancer model.

Authors:  Shruthi Bharadwaj; Ramana Vishnubhotla; Sun Shan; Chinmay Chauhan; Michael Cho; Sarah C Glover
Journal:  J Biomed Biotechnol       Date:  2011-10-01

4.  Reproducibility warning: The curious case of polyethylene glycol 6000 and spheroid cell culture.

Authors:  Simona Serrati; Chiara Martinelli; Antonio Palazzo; Rosa Maria Iacobazzi; Mara Perrone; Quy K Ong; Zhi Luo; Ahmet Bekdemir; Giulia Pinto; Ornella Cavalleri; Annalisa Cutrignelli; Valentino Laquintana; Nunzio Denora; Francesco Stellacci; Silke Krol
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

5.  Comparative Investigation of Cellular Effects of Polyethylene Glycol (PEG) Derivatives.

Authors:  Ha Pham Le Khanh; Dániel Nemes; Ágnes Rusznyák; Zoltán Ujhelyi; Pálma Fehér; Ferenc Fenyvesi; Judit Váradi; Miklós Vecsernyés; Ildikó Bácskay
Journal:  Polymers (Basel)       Date:  2022-01-11       Impact factor: 4.329

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.